2024 was another year of solid financial performance by BioSyent Inc. and marked our 15th consecutive year of profitability.
BioSyent is proudly Canadian, listed on the TSX Venture stock exchange, with an all-Canadian team of employees who are dedicated to enhancing Canadian healthcare and work to find, develop and make available innovative medicines for Canadian patients and their healthcare professionals. Our products support many thousands of Canadians each year.
